Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 7, 2026
[A Case of Hepatic Sarcoidosis Diagnosed by Liver Resection]Yoshiaki Ohmura, Masaki Kashiwazaki, Hisataka Ogawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Analysis of combination chemotherapy with docetaxel and nedaplatin for esophageal cancer]Junji Kawada, Kazuhiro Iwase, Koichi Deguchi, et al.
Endoscopy|August 31, 2016
Endoscopic anti-reflux valve for post-esophagectomy reflux: an animal studyYoshitomo Yanagimoto, Makoto Yamasaki, Hirotsugu Nagase, et al.
Surgical Endoscopy|November 7, 2015
A novel approach of optical biopsy using probe-based confocal laser endomicroscopy for peritoneal metastasisHisashi Hara, Tsuyoshi Takahashi, Rie Nakatsuka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Efficacy of capecitabine/cisplatin chemotherapy after failure of all conventional therapies in patients with advanced gastric cancer]Kazuhiro Nishikawa, Kazuhiro Iwase, Toyokazu Aono, et al.
Clinical Medicine Insights. Gastroenterology|July 18, 2018
Successful Endoscopic Treatment of Post-esophagectomy Refractory Reflux Using OverStitch: The First Clinical CaseHirotsugu Nagase, Makoto Yamasaki, Yoshitomo Yanagimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A case of HER2-positive advanced gastric cancer successfully treated with a combination of capecitabine, cisplatin, and trastuzumab as first-line chemotherapy]Koichi Deguchi, Kazuhiro Nishikawa, Kazuhiro Iwase, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 30, 2025
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: short-term outcomes of a multicenter, phase II study (OGSG1902)Ryo Tanaka, Shunji Endo, Toshifumi Yamaguchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 21, 2026
Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902)Shunji Endo, Ryo Tanaka, Toshifumi Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel]Kazuhiro Nishikawa, Kazuhiro Iwase, Toyokazu Aono, et al.
Pageof 4